These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8239903)

  • 41. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
    Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antitumor activity of indolylpyrimidines: marine natural product meridianin D analogues.
    Radwan MA; El-Sherbiny M
    Bioorg Med Chem; 2007 Feb; 15(3):1206-11. PubMed ID: 17157024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation.
    Carraro F; Naldini A; Pucci A; Locatelli GA; Maga G; Schenone S; Bruno O; Ranise A; Bondavalli F; Brullo C; Fossa P; Menozzi G; Mosti L; Modugno M; Tintori C; Manetti F; Botta M
    J Med Chem; 2006 Mar; 49(5):1549-61. PubMed ID: 16509573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on immunostimulating derivatives: synthesis of some pyrrolo[1,2-c]pyrimidines.
    Bahaji EH; Tronche P; Couquelet J; Harraga S; Panouse-Perrin J; Rubat C
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2126-8. PubMed ID: 1797434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel pyrimidine and purine derivatives of L-ascorbic acid: synthesis and biological evaluation.
    Raić-Malić S; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; De Clercq E; Mintas M
    J Med Chem; 1999 Jul; 42(14):2673-8. PubMed ID: 10411487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
    Singh P; Kaur P; Luxami V; Kaur S; Kumar S
    Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors.
    Hayakawa M; Kaizawa H; Moritomo H; Koizumi T; Ohishi T; Yamano M; Okada M; Ohta M; Tsukamoto S; Raynaud FI; Workman P; Waterfield MD; Parker P
    Bioorg Med Chem Lett; 2007 May; 17(9):2438-42. PubMed ID: 17339109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, SAR, and antitumor properties of diamino-C,N-diarylpyrimidine positional isomers: inhibitors of lysophosphatidic acid acyltransferase-beta.
    Gong B; Hong F; Kohm C; Jenkins S; Tulinsky J; Bhatt R; De Vries P; Singer JW; Klein P
    Bioorg Med Chem Lett; 2004 May; 14(9):2303-8. PubMed ID: 15081029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
    Lin R; Johnson SG; Connolly PJ; Wetter SK; Binnun E; Hughes TV; Murray WV; Pandey NB; Moreno-Mazza SJ; Adams M; Fuentes-Pesquera AR; Middleton SA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2333-7. PubMed ID: 19286381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2.
    Miyazaki Y; Tang J; Maeda Y; Nakano M; Wang L; Nolte RT; Sato H; Sugai M; Okamoto Y; Truesdale AT; Hassler DF; Nartey EN; Patrick DR; Ho ML; Ozawa K
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1773-8. PubMed ID: 17276055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity.
    Hocková D; Holý A; Masojídková M; Andrei G; Snoeck R; De Clercq E; Balzarini J
    J Med Chem; 2003 Nov; 46(23):5064-73. PubMed ID: 14584956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines.
    Tashiro T; Hongo N; Nakagawa R; Seino K; Watarai H; Ishii Y; Taniguchi M; Mori K
    Bioorg Med Chem; 2008 Oct; 16(19):8896-906. PubMed ID: 18790646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines.
    Manetti F; Brullo C; Magnani M; Mosci F; Chelli B; Crespan E; Schenone S; Naldini A; Bruno O; Trincavelli ML; Maga G; Carraro F; Martini C; Bondavalli F; Botta M
    J Med Chem; 2008 Mar; 51(5):1252-9. PubMed ID: 18257513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and biological properties of 4-hydroxy, 4-thio-5-pyrimidine derivatives.
    Pluta J; Gubrynowicz O; Cieplik J
    Boll Chim Farm; 1999 Jan; 138(1):30-3. PubMed ID: 10326313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Protected mercaptoalkylpyrimidinones: synthesis and test for immunostimulating activity].
    Briel D; Drössler K; Rybak A; Holzer M; Dobner B
    Pharmazie; 2005 Jun; 60(6):415-7. PubMed ID: 15997828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-alpha.
    Kawamoto S; Oritani K; Asakura E; Ishikawa J; Koyama M; Miyano K; Iwamoto M; Yasuda S; Nakakubo H; Hirayama F; Ishida N; Ujiie H; Masaie H; Tomiyama Y
    Exp Hematol; 2004 Sep; 32(9):797-805. PubMed ID: 15345280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation.
    Schenone S; Bruno O; Ranise A; Bondavalli F; Brullo C; Fossa P; Mosti L; Menozzi G; Carraro F; Naldini A; Bernini C; Manetti F; Botta M
    Bioorg Med Chem Lett; 2004 May; 14(10):2511-7. PubMed ID: 15109642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and SAR of 6-chloro-4-fluoroalkylamino-2-heteroaryl-5-(substituted)phenylpyrimidines as anti-cancer agents.
    Zhang N; Ayral-Kaloustian S; Nguyen T; Hernandez R; Lucas J; Discafani C; Beyer C
    Bioorg Med Chem; 2009 Jan; 17(1):111-8. PubMed ID: 19041247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors.
    Huang H; Hutta DA; Hu H; DesJarlais RL; Schubert C; Petrounia IP; Chaikin MA; Manthey CL; Player MR
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2355-61. PubMed ID: 18342505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
    Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.